We are pleased to announce the winner of the 2025 Highly Cited Paper Award, recognizing outstanding research published in Exploration of Neuroprotective Therapy that has demonstrated significant scholarly impact and strong engagement within the academic community.

2025 Award-Winning Paper

The following article has been selected for the 2025 Highly Cited Paper Award, in recognition of its remarkable contributions:

Biomarkers in neurodegenerative diseases: a broad overview

Authors: Sathish Selvam, Velpandi Ayyavoo*

Published: April 16, 2024

DOI: https://doi.org/10.37349/ent.2024.00075

Belongs to the Special Issue: The Future of Biomarkers in CNS Diseases

Selection Criteria

The award recognizes articles that have achieved notable influence in the field. This year's evaluation was conducted based on several factors, including:

– Articles published in 2024–2025

– Citation performance in 2025 according to the Web of Science (WoS) database

Award Benefits

In recognition of their achievement, the winning author team will receive:

• An official Certificate of Award

• A financial reward of USD 500

• A 100% Article Processing Charge (APC) discount voucher (valued at USD 2,000) for the corresponding author, applicable to a future submission to ENT

We warmly congratulate the authors of the award-winning article and sincerely thank them for their valuable contribution to the advancement of research on neurodegenerative diseases. Their work exemplifies the journal’s commitment to high-quality research that contributes meaningfully to the field of neurodegeneration and neuroscience

Looking Ahead: Join Us in Shaping the Future

ENT is committed to providing an open and accessible platform for impactful scientific communication. As the journal continues to grow, we remain dedicated to publishing impactful research that advances understanding and treatment strategies for neurological diseases. We warmly invite researchers and clinicians worldwide to share their latest findings and groundbreaking work with Exploration of Neuroprotective Therapy and join us in advancing knowledge and collaboration in this important field.

We look forward to receiving more outstanding contributions in the years ahead and to working together with the global research community to advance the field.